Epic Wound Care LLC, a United EcoEnergy Corp. Company, Achieves FDA Manufacturer Registration Status

NEW YORK, NY--(Marketwire - February 17, 2010) - United EcoEnergy Corp.'s (OTCBB: UEEC) principal operating subsidiary, Epic Wound Care, Inc., today announced that it has successfully accomplished its manufacturer’s registration. United EcoEnergy develops, manufactures and markets products and technologies in the healthcare sector.

The registration describes the product as “Gauze/Sponge Nonresorbable for External Use” and is grouped as a Device Class 1 which is exempt from premarket submission. The product will be marketed under the registered brand names ActCel Gauze™, ActJel Gauze™ and ABC Gauze™ and Hemostyp™. These brand names are owned by Epic or its distributor Coreva Health Care Sciences.

Craig Bluth, President of Coreva, stated that, “The completed registration allows the product to be marketed which will be in packaging configurations to address specific market segments underspecific brand identification and labels for each market. We now can fulfill our present orders while continuing to build our product line and commence shipping of our product worldwide.”

It is a very exciting and important time for us and the product, said Mr. Bluth. We have recently attended numerous events catered to the US military and retail markets. The product was extremely well received and we can now address those markets.

About Epic Wound Care. Inc. (www.abcgauze.com)

Epic has developed a ground-breaking gauze product designed for the wound care market. The gauze can be used on any wound where bleeding is present. Upon contact with moisture, the gauze forms a gel-like substance that acts as a homeostatic agent to address bleeding quickly. Once bleeding has ceased and coagulation has occurred, the product can be rinsed away with saline solution or lukewarm water.

About United EcoEnergy

United EcoEnergy Corp (UEEC) develops, manufactures and markets products and technologies in the healthcare sector. UEEC’s principal operating subsidiary is Epic Wound Care, Inc. which produces a hemostatic gauze, a collagen-like natural substance created from chemically treated cellulose, that is designed to address severe bleeding in wound care applications. The Company is focused on identifying emerging healthcare products and technologies for strategic partnership or acquisition.

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipates” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.